Facilitate the Return to Work of Cancer Survivors

NCT03666936 | Completed

• 1 other identifier: OCCA_Welcom_2017
• Study Type: interventional
• Target: 34
• Locations: 1 country
• Sites: 1

Brief Summary

Cancer patients could experience physical limitations, cognitive symptoms, fatigue and pain, that could be perceived at diagnosis but may also occur during treatment, limiting the person from carrying out their activities of daily living, including work tasks. Return to work is a major goal, as it facilitates the patient's ability to deal with the disease and improve general health. At present, there is no path aimed at supporting cancer patients in the return to work process. Because of this, the investigators want to assess the feasibility of a multidisciplinary social-health care pathway aimed at manage the difficulties that cancer patients might perceive in the return to work process.

Conditions

Neoplasms; Return to Work

Keywords

Cancer survivors; Return to work; Italy; Occupational Therapy; Comprehensive Health Care; Neoplasm

Outcome Measures

Primary Outcomes (1)

• number, type and duration of intervention provided (information, occupational therapy, social support) and, for those who have been offered the involvement of the employer, the number of those who have accepted this intervention (Feasibility indicator_1)

  all the needs expressed by cancer patients and the related social-healthcare actions implemented will be recorded. To evaluate the feasibility of the social-healthcare pathway we will record the actions implemented successfully as well as the actions not implemented or ineffective.

  through study completion, on average 24 months.

Secondary Outcomes (6)

• difficulties faced by cancer patients in the return to work process, collected by a guided interview (Feasibility indicator_2).

  through study completion, on average 24 months.

• ratio of cancer patients who have returned to work/not returned to work (Feasibility indicator_3).

  through study completion, on average 24 months.

• number of healthcare providers directly informed about UNAMANO (Feasibility indicator_4).

  through study completion, on average 24 months.

• number of healthcare professionals who refer patients to UNAMANO (Feasibility indicator_5).

  through study completion, on average 24 months.

• number of individuals that contact In-Forma Salute to seek information regarding UNAMANO without being referred by a healthcare professional (Feasibility indicator_6).

  through study completion, on average 24 months.

Study Arms (1)

Intervention

EXPERIMENTAL

Social-health care intervention

Other: Social-health care intervention

Interventions

Social-health care intervention OTHER

Cancer survivors enrolled in the study could receive support from the Occupational Therapist and/or from the social care professionist to overcome the difficulties encounter at work or to facilitate work reintegration.

Intervention

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• adults with cancer diagnosis and employed at the time of diagnosis

Sponsors & Collaborators

• Azienda USL Reggio Emilia - IRCCS: lead

Study Sites (1)

Local Health Authority of Reggio Emilia-IRCCS

Reggio Emilia, Italy

Location

Related Publications (2)

• Paltrinieri S, Fugazzaro S, Bertozzi L, Bassi MC, Pellegrini M, Vicentini M, Mazzini E, Costi S. Return to work in European Cancer survivors: a systematic review. Support Care Cancer. 2018 Sep;26(9):2983-2994. doi: 10.1007/s00520-018-4270-6. Epub 2018 May 29.

  PMID: 29845421 BACKGROUND

• Paltrinieri S, Vicentini M, Mazzini E, Ricchi E, Fugazzaro S, Mancuso P, Giorgi Rossi P, Costi S. Factors influencing return to work of cancer survivors: a population-based study in Italy. Support Care Cancer. 2020 Feb;28(2):701-712. doi: 10.1007/s00520-019-04868-0. Epub 2019 May 25.

  PMID: 31129762 BACKGROUND

MeSH Terms

Conditions

Neoplasms

Study Officials

• Elisa Mazzini

  Local Helath Authority of Reggio Emilia-IRCCS

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER GOV
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 20, 2018
• First Posted: September 12, 2018
• Study Start: May 1, 2018
• Primary Completion: January 31, 2020
• Study Completion: January 31, 2021
• Last Updated: June 13, 2025

Record last verified: 2021-07

Data Sharing

• IPD Sharing: Will not share

Locations

IT (1)